<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0004326'>Cachexia</z:hpo> is a consequence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden caused by ill-defined catabolic alterations in muscle protein turnover </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: We aimed to explore the effect of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden and resection on muscle protein turnover in patients with nonmetastatic <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), which is a surgically curable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> that induces <z:hpo ids='HP_0004326'>cachexia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: We recruited the following 2 groups: patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> [n = 13; mean ± <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> age: 66 ± 3 y; BMI (in kg/m(2)): 27.6 ± 1.1] and matched healthy controls (n = 8; age: 71 ± 2 y; BMI: 26.2 ± 1) </plain></SENT>
<SENT sid="3" pm="."><plain>Control subjects underwent a single study, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients were studied twice before and ~6 wk after surgical resection to assess muscle protein synthesis (MPS), muscle protein breakdown (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPB</z:e>), and muscle mass by using dual-energy X-ray absorptiometry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Leg muscle mass was lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients than in control subjects (6290 ± 456 compared with 7839 ± 617 g; P &lt; 0.05) and had an additional decline after surgery (5840 ± 456 g; P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Although postabsorptive MPS was unaffected, catabolic changes with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden included the complete blunting of postprandial MPS (0.038 ± 0.004%/h in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> group compared with 0.065 ± 0.006%/h in the control group; P &lt; 0.01) and a trend toward increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPB</z:e> under postabsorptive conditions (P = 0.09) </plain></SENT>
<SENT sid="6" pm="."><plain>Although surgical resection exacerbated <z:hpo ids='HP_0003202'>muscle atrophy</z:hpo> (-7.2%), catabolic changes in protein metabolism had normalized 6 wk after surgery </plain></SENT>
<SENT sid="7" pm="."><plain>The recovery in postprandial MPS after surgery was inversely related to the degree of <z:hpo ids='HP_0003202'>muscle atrophy</z:hpo> (r = 0.65, P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients display reduced postprandial MPS and a trend toward increased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPB</z:e>, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> resection reverses these derangements </plain></SENT>
<SENT sid="9" pm="."><plain>With no effective treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0004326'>cachexia</z:hpo>, future therapies directed at preserving muscle mass should concentrate on alleviating proteolysis and enhancing anabolic responses to nutrition before surgery while augmenting muscle anabolism after resection </plain></SENT>
</text></document>